Loading...
•
Nov 30, 2019
AngioDynamics Q2 2020 Earnings Report
AngioDynamics' financial performance remained consistent with the prior year, marked by strategic acquisitions and growth in key product lines.
Key Takeaways
AngioDynamics reported flat net sales of $70.0 million compared to the prior-year quarter. Gross margin increased by 140 basis points to 59.3%. The company announced the acquisition of the C3 Wave PICC tip location system. They reiterate FY2020 guidance expecting net sales between $280 to $286 million and adjusted EPS between $0.10 to $0.15.
Net sales were $70.0 million, consistent with the prior-year quarter.
Gross margin increased 140 basis points year over year to 59.3%.
GAAP loss per share was $0.07; adjusted earnings per share was $0.06.
Acquired C3 Wave PICC tip location system subsequent to quarter end.
AngioDynamics
AngioDynamics
AngioDynamics Revenue by Segment
AngioDynamics Revenue by Geographic Location
Revenue by Segment
Med Tech Revenue
CapyFin.comMed Device Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The Company reiterates its fiscal year 2020 guidance, which includes investments related to the full-market launch of the products acquired from Eximo anticipated in the second half of the fiscal year. Specifically, the Company continues to expect net sales in the range of $280 to $286 million and gross margin in the range of 58% to 59%. Adjusted earnings per share is expected in the range of $0.10 to $0.15.
Revenue & Expenses
Visualization of income flow from segment revenue to net income